55 related articles for article (PubMed ID: 2125776)
21. [Clinical immunological features and interferon therapy in chronic hepatitis C].
Pár A; Paál M; Gógl A; Gervain J; Szekeres J; Sipos J; Beró T; Hütter E; Berencsi G; Kádas I
Orv Hetil; 1995 Jan; 136(1):9-18. PubMed ID: 7845665
[TBL] [Abstract][Full Text] [Related]
22. [Generation of neutralizing anti-interferon antibodies and factors influencing their production in chronic hepatitis B patients receiving recombinant interferon-alpha treatment].
Mao QG; Luo KX; Zhang MX; Liu D; Hou JL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1319-22. PubMed ID: 14678902
[TBL] [Abstract][Full Text] [Related]
23. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
Chemello L; Cavalletto L; Bernardinello E; Guido M; Pontisso P; Alberti A
J Hepatol; 1995; 23 Suppl 2():8-12. PubMed ID: 8720287
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
25. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
26. Post-transfusion etiology and non-cirrhotic histology improve the remission rate of chronic hepatitis C during interferon treatment.
Halpern Z; Arber N; Hallak A; Konikoff F; Santo M; Moshkowitz M; Tomny E; Gilat T
Isr J Med Sci; 1995 Jun; 31(6):341-4. PubMed ID: 7607851
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
Hoofnagle JH; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Peters M; Waggoner JG; Park Y; Jones EA
N Engl J Med; 1986 Dec; 315(25):1575-8. PubMed ID: 3097544
[TBL] [Abstract][Full Text] [Related]
28. [Therapy of chronic viral hepatitis with recombinant interferon-alpha].
Ferenci P
Acta Med Austriaca; 1992; 19(2):49-55. PubMed ID: 1509859
[TBL] [Abstract][Full Text] [Related]
29. Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up.
Bresci G; Parisi G; Banti S; Bertoni M
Eur J Med; 1993; 2(6):349-52. PubMed ID: 8252180
[TBL] [Abstract][Full Text] [Related]
30. [3 cases of polyarthritis treated with recombinant alfa interferon].
Chazerain P; Meyer O; Ribard P; De Bandt M; Mechelany C; Marcellin P; Bernard JF; Grossin M; Kahn MF
Rev Rhum Mal Osteoartic; 1992 May; 59(5):303-9. PubMed ID: 1411190
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).
Hopf U; Möller B; Küther D; Stemerowicz R; Lobeck H; Lüdtke-Handjery A; Walter E; Blum HE; Roggendorf M; Deinhardt F
J Hepatol; 1990 Jan; 10(1):69-76. PubMed ID: 2106548
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of chronic non-A, non-B hepatitis with a combination therapy of interferon and an immunopotentiator].
Ooka T
Nihon Rinsho; 1988 Dec; 46(12):2703-14. PubMed ID: 3149344
[No Abstract] [Full Text] [Related]
33. [Treatment of chronic hepatitis C with interferon alpha].
Marcellin P; Benhamou JP
Gastroenterol Clin Biol; 1991; 15(8-9):613-4. PubMed ID: 1752372
[No Abstract] [Full Text] [Related]
34. [Long-term treatment for non-A, non-B chronic hepatitis--effects on hepatitis C virus (HCV)].
Omata M; Tada M; Hosoda K; Takano S; Tagawa M; Imazeki F; Yokosuka O; Ito Y; Ohto M
Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1430-5. PubMed ID: 2120488
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C.
McCarthy LJ; Hsueh Y; Danielson C; Thelia A
Indiana Med; 1991 Nov; 84(11):812. PubMed ID: 1761856
[No Abstract] [Full Text] [Related]
36. A pilot study of thymus extract in chronic non-A, non-B hepatitis.
Civeira MP; Castilla A; Morte S; Serrano M; Prieto J
Aliment Pharmacol Ther; 1989 Aug; 3(4):395-401. PubMed ID: 2518854
[TBL] [Abstract][Full Text] [Related]
37. [Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha].
Hopf U; Möller B; König V; Küther S; Lobeck H; Huhn D
Z Gastroenterol; 1990 Sep; 28(9):453-7. PubMed ID: 2125776
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
39. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
Ohnishi K; Nomura F; Nakano M
Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
[TBL] [Abstract][Full Text] [Related]
40. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
Bresci G; Gambardella L; Parisi G; Banti S; Scatena F; Bertoni M; Capria A
Int J Clin Pharmacol Res; 1995; 15(5-6):175-9. PubMed ID: 8835615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
